HomeSBMFF • OTCMKTS
add
Sino Biopharmaceutical Ltd
Previous close
$0.41
Year range
$0.31 - $0.47
Market cap
54.15B HKD
Avg Volume
364.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 7.94B | 11.14% |
Operating expense | 4.78B | 10.58% |
Net income | 1.51B | 139.69% |
Net profit margin | 19.01 | 115.78% |
Earnings per share | — | — |
EBITDA | 1.98B | 8.88% |
Effective tax rate | 16.99% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.18B | -15.93% |
Total assets | 66.70B | 1.62% |
Total liabilities | 24.58B | -15.76% |
Total equity | 42.12B | — |
Shares outstanding | 18.21B | — |
Price to book | 0.23 | — |
Return on assets | 6.50% | — |
Return on capital | 8.37% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 1.51B | 139.69% |
Cash from operations | 1.54B | 15.25% |
Cash from investing | -1.02B | 49.91% |
Cash from financing | -2.05B | -1.42% |
Net change in cash | -1.52B | 43.37% |
Free cash flow | 1.09B | 36.59% |
About
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020.
The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
CEO
Founded
2000
Website
Employees
24,437
